|
Market Cap | 37.55M | EPS (ttm) | -0.11 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 0.24 | EPS Q/Q | -316.17% |
Dividend | - | Sales Q/Q | - |
Insider Own | 38.41% | Inst Own | 20.36% |
Insider Trans | 0.00% | Inst Trans | 6.72% |
Short Float | 2.31% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 997.61K | 52W Range | 1.22 - 18.50 |
|
|
|
Zapata Computing Holdings, Inc. operates as a generative AI company. It provides data science and engineering techniques for solutions on an industrial scale. The company was founded by Christopher Savoie, Alan Aspuru-Guzik, Yudong Cao, Jonathan Olson, Peter Johnson, and Jonathan Romero-Fontalvo in 2017 and is headquartered in Boston, MA. |
|
|
|
Market Cap | 174.96M | EPS (ttm) | -2.48 |
P/E | - | EPS this Y | -30.65% |
Forward P/E | - | EPS next Y | 25.51% |
PEG | - | EPS past 5Y | -27.17% |
P/S | 4.16 | EPS next 5Y | - |
P/B | 2.64 | EPS Q/Q | -90.12% |
Dividend | - | Sales Q/Q | 34.98% |
Insider Own | 55.51% | Inst Own | 27.84% |
Insider Trans | -0.05% | Inst Trans | -5.10% |
Short Float | 8.18% | Earnings | Apr 30/a |
Analyst Recom | 1.67 | Target Price | 16.60 |
Avg Volume | 174.95K | 52W Range | 7.77 - 33.13 |
|
|
|
CVRx, Inc. engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It operates through the United States, Germany, and Other Countries geographical segments. The company was founded by Robert S. Kieval and Tyler P. Lipschultz in August 2001 and is headquartered in Minneapolis, MN. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Palmer Craig E. | SVP, U.S. SALES | Mar 25 '24 | Option Exercise | 0.24 | 934 | 221 | 1,229 | Mar 27 04:56 PM | JOHNSON & JOHNSON | 10% Owner | Feb 29 '24 | Option Exercise | 0.72 | 3,855 | 2,792 | 4,103,430 | Mar 06 03:42 PM | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Feb 20 '24 | Option Exercise | 5.14 | 5,000 | 25,705 | 5,000 | Feb 22 06:05 PM | VERRASTRO PAUL | CHIEF MKTG & STRAT OFFICER | Feb 20 '24 | Sale | 21.91 | 2,545 | 55,748 | 2,455 | Feb 22 06:05 PM | JOHNSON & JOHNSON | 10% Owner | Feb 16 '24 | Sale | 25.81 | 3,725 | 96,142 | 4,099,575 | Mar 06 03:42 PM |
|
|
|
|
Market Cap | 20.85M | EPS (ttm) | 2.98 |
P/E | 1.05 | EPS this Y | 168.72% |
Forward P/E | - | EPS next Y | -278.08% |
PEG | - | EPS past 5Y | 24.44% |
P/S | 0.29 | EPS next 5Y | -0.10% |
P/B | 0.35 | EPS Q/Q | -207.90% |
Dividend | - | Sales Q/Q | -100.00% |
Insider Own | 7.66% | Inst Own | 47.69% |
Insider Trans | 0.00% | Inst Trans | 7.63% |
Short Float | 0.34% | Earnings | Feb 13/a |
Analyst Recom | 1.67 | Target Price | 23.00 |
Avg Volume | 20.55K | 52W Range | 3.01 - 6.91 |
|
|
|
MEI Pharma, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical compounds. Its programs include Voruciclib and ME-344. The company was founded on December 1, 2000, and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Anson Funds Management LP | 10% Owner | Sep 22 '23 | Buy | 6.85 | 48,060 | 329,331 | 864,188 | Sep 25 07:43 PM | Funicular Funds, LP | 10% Owner | Sep 22 '23 | Buy | 6.85 | 32,040 | 219,554 | 460,840 | Sep 25 07:41 PM | Anson Funds Management LP | 10% Owner | Sep 21 '23 | Buy | 6.46 | 33,600 | 217,110 | 816,128 | Sep 22 09:21 PM | Funicular Funds, LP | 10% Owner | Sep 21 '23 | Buy | 6.46 | 22,400 | 144,740 | 428,800 | Sep 22 09:19 PM | Anson Funds Management LP | 10% Owner | Sep 20 '23 | Buy | 6.01 | 120,000 | 721,116 | 782,528 | Sep 22 09:21 PM |
|
|
| |
|
Market Cap | 7.55B | EPS (ttm) | 6.82 |
P/E | 29.47 | EPS this Y | 5.47% |
Forward P/E | 24.65 | EPS next Y | 12.80% |
PEG | 3.74 | EPS past 5Y | 8.46% |
P/S | 9.97 | EPS next 5Y | 7.89% |
P/B | 5.89 | EPS Q/Q | -1.83% |
Dividend | 1.50% | Sales Q/Q | 3.52% |
Insider Own | 2.32% | Inst Own | 100.95% |
Insider Trans | -0.45% | Inst Trans | -0.77% |
Short Float | 2.90% | Earnings | May 07/b |
Analyst Recom | 2.65 | Target Price | 241.77 |
Avg Volume | 394.42K | 52W Range | 199.33 - 303.85 |
|
|
|
MarketAxess Holdings, Inc. engages in an electronic trading platform that allows investment industry professionals to trade corporate bonds and other types of fixed-income instruments. It operates through the Americas, Europe, and Asia geographical segments. The company was founded by Richard Mitchell Mcvey on April 11, 2000, and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McPherson Kevin M | Chief Revenue Officer | Feb 16 '24 | Sale | 221.26 | 2,000 | 442,520 | 70,092 | Feb 16 05:00 PM | McVey Richard M | Executive Chairman | Jan 10 '24 | Option Exercise | 203.72 | 16,037 | 3,267,058 | 652,382 | Jan 12 04:15 PM | McPherson Kevin M | Chief Revenue Officer | Dec 08 '23 | Sale | 260.50 | 920 | 239,660 | 68,959 | Dec 11 04:15 PM | McPherson Kevin M | Chief Revenue Officer | Nov 27 '23 | Sale | 230.95 | 1,020 | 235,569 | 69,879 | Nov 28 04:15 PM | CONCANNON CHRISTOPHER R | Chief Executive Officer | Aug 14 '23 | Buy | 238.42 | 4,270 | 1,018,060 | 47,166 | Aug 15 04:15 PM |
|
|
|
|
Market Cap | 12.96M | EPS (ttm) | -3.14 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 9.90% |
P/S | 0.23 | EPS next 5Y | 15.00% |
P/B | - | EPS Q/Q | 45.73% |
Dividend | - | Sales Q/Q | -25.55% |
Insider Own | 3.57% | Inst Own | 50.97% |
Insider Trans | 0.00% | Inst Trans | -7.96% |
Short Float | 0.03% | Earnings | Apr 04/b |
Analyst Recom | 1.00 | Target Price | 20.00 |
Avg Volume | 17.63K | 52W Range | 1.66 - 5.50 |
|
|
|
Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland. |
|
| |
|
Market Cap | 6.92M | EPS (ttm) | -33.53 |
P/E | - | EPS this Y | 76.08% |
Forward P/E | - | EPS next Y | 51.11% |
PEG | - | EPS past 5Y | 70.74% |
P/S | - | EPS next 5Y | - |
P/B | 0.13 | EPS Q/Q | 87.85% |
Dividend | - | Sales Q/Q | - |
Insider Own | 4.44% | Inst Own | 17.62% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 1.88% | Earnings | Mar 28/b |
Analyst Recom | 1.00 | Target Price | 32.50 |
Avg Volume | 203.97K | 52W Range | 3.47 - 61.20 |
|
|
|
Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC. |
|
|
|
Market Cap | 356.79M | EPS (ttm) | -0.26 |
P/E | - | EPS this Y | -5.44% |
Forward P/E | - | EPS next Y | 8.18% |
PEG | - | EPS past 5Y | 50.65% |
P/S | 3.46 | EPS next 5Y | 15.00% |
P/B | 0.54 | EPS Q/Q | 4.80% |
Dividend | - | Sales Q/Q | -54.98% |
Insider Own | 0.34% | Inst Own | 43.69% |
Insider Trans | 0.00% | Inst Trans | 4.18% |
Short Float | 19.64% | Earnings | Mar 07/b |
Analyst Recom | 3.11 | Target Price | 1.50 |
Avg Volume | 18.90M | 52W Range | 0.79 - 2.94 |
|
|
|
FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Feasel Mark | EVP & Ch. Commercial Officer | Mar 25 '24 | Option Exercise | 0.00 | 83,493 | 0 | 164,343 | Mar 27 04:34 PM | Dolger Joshua | General Counsel & Corp Sec | Dec 11 '23 | Option Exercise | 0.00 | 4,710 | 0 | 21,311 | Dec 13 04:44 PM | Few Jason | CEO | Dec 11 '23 | Option Exercise | 0.00 | 20,833 | 0 | 841,954 | Dec 13 04:47 PM | Bishop Michael S. | EVP, TREASURER & CFO | Dec 11 '23 | Option Exercise | 0.00 | 6,522 | 0 | 175,579 | Dec 13 04:48 PM | Feasel Mark | EVP & Ch. Commercial Officer | Dec 11 '23 | Option Exercise | 0.00 | 6,522 | 0 | 83,310 | Dec 13 04:42 PM |
|
|
| |
|
Market Cap | 39.34M | EPS (ttm) | -2.02 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 18.24% |
P/S | 0.09 | EPS next 5Y | - |
P/B | 0.64 | EPS Q/Q | -8772.38% |
Dividend | - | Sales Q/Q | 15.58% |
Insider Own | 26.47% | Inst Own | 44.35% |
Insider Trans | 0.00% | Inst Trans | 1.44% |
Short Float | 3.64% | Earnings | May 13/a |
Analyst Recom | 3.00 | Target Price | 5.00 |
Avg Volume | 28.79K | 52W Range | 1.99 - 4.00 |
|
|
|
Ampco-Pittsburgh Corp. is engaged in the manufacture and sale of custom designed engineering products. It operates through the Forged and Cast Engineered Products, and Air and Liquid Processing segments. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls and open-die forged products. Forged hardened steel rolls are used primarily in cold rolling mills by producers of steel, aluminum and other metals. The Air and Liquid Processing segment includes the Aerofin, Buffalo Air Handling, and Buffalo Pumps divisions. The company was founded in 1929 and is headquartered in Carnegie, PA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McNair Darrell L | Director | Sep 13 '23 | Buy | 3.12 | 3,000 | 9,360 | 6,640 | Sep 20 12:46 PM | DiSanto Frederick D. | Director | Jun 29 '23 | Buy | 2.99 | 7,399 | 22,123 | 47,177 | Jul 03 11:41 AM | DiSanto Frederick D. | Director | Jun 28 '23 | Buy | 2.85 | 918 | 2,616 | 39,778 | Jul 03 11:41 AM | DiSanto Frederick D. | Director | Jun 23 '23 | Buy | 2.94 | 2,000 | 5,880 | 38,860 | Jun 26 11:35 AM | DiSanto Frederick D. | Director | Jun 22 '23 | Buy | 2.94 | 5,000 | 14,700 | 36,860 | Jun 26 11:35 AM |
|
|
|
|
Market Cap | 1.69M | EPS (ttm) | -6.00 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | 5.51% |
P/S | 0.08 | EPS next 5Y | - |
P/B | 0.06 | EPS Q/Q | - |
Dividend | - | Sales Q/Q | - |
Insider Own | 24.02% | Inst Own | 0.08% |
Insider Trans | 0.00% | Inst Trans | -45.71% |
Short Float | 4.54% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 388.67K | 52W Range | 0.47 - 8.60 |
|
|
|
Lion Group Holding Ltd. operates a trading platform that offers a wide spectrum of products and services, including total return service (TRS) trading, contract-for-difference (CFD) trading, insurance brokerage, and futures and securities brokerage. It also owns a SPAC sponsorship team that helps guide private companies through their listing journey while creating value for Lion itself. The company was founded in 2015 and is headquartered in Singapore. |
|
|
|
Market Cap | 353.61M | EPS (ttm) | 0.21 |
P/E | 53.52 | EPS this Y | -61.96% |
Forward P/E | 24.17 | EPS next Y | 165.71% |
PEG | 3.57 | EPS past 5Y | -27.96% |
P/S | 0.49 | EPS next 5Y | 15.00% |
P/B | 0.77 | EPS Q/Q | -24.12% |
Dividend | 1.78% | Sales Q/Q | -9.02% |
Insider Own | 25.06% | Inst Own | 96.50% |
Insider Trans | 0.00% | Inst Trans | 1.33% |
Short Float | 19.22% | Earnings | May 02/b |
Analyst Recom | 1.00 | Target Price | 19.00 |
Avg Volume | 447.17K | 52W Range | 11.21 - 16.75 |
|
|
|
Marcus Corp. engages in the lodging and entertainment industries. It operates through the following business segments: Theatres and Hotels & Resorts. The Theatres segment includes multiscreen motion picture theatres and a family entertainment center. The Hotels & Resorts segment owns and operates full service hotels and resorts. The company was founded by Ben Marcus on November 1, 1935 and is headquartered in Milwaukee, WI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Marcus Gregory S | President and CEO | Jul 25 '23 | Option Exercise | 13.04 | 57,500 | 749,800 | 248,368 | Jul 28 09:43 AM | GERSHOWITZ DIANE M | Director | May 30 '23 | Option Exercise | 13.45 | 1,000 | 13,450 | 33,374 | May 31 05:07 PM | SELIG ALLAN H | Director | May 30 '23 | Option Exercise | 13.45 | 1,000 | 13,450 | 49,989 | May 31 05:11 PM | STARK BRIAN JAY | Director | May 24 '23 | Option Exercise | 13.45 | 1,000 | 13,450 | 31,880 | May 26 05:59 PM | MILSTEIN PHILIP L | Director | May 11 '23 | Option Exercise | 13.45 | 1,000 | 13,450 | 62,313 | May 15 04:56 PM |
|
|
|